A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Chronic Pancreatitis.

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Chronic Pancreatitis.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2012

At a glance

  • Drugs Tanezumab (Primary)
  • Indications Abdominal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Apr 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 14 Mar 2011 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 14 Feb 2011 Planned end date changed from 1 Sep 2011 to 1 Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top